Gastric cancer, also known as stomach cancer, often leads to the spread of cancer cells to the lining of the abdomen, known as peritoneal metastasis. Traditional chemotherapy struggles to effectively treat these metastases due to poor blood supply to the peritoneum. A new technique called Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) shows promise in addressing this challenge.
What is PIPAC?
PIPAC delivers chemotherapy directly into the abdominal cavity as a pressurized aerosol. This method ensures better distribution and deeper penetration of the drugs into the cancerous tissues compared to conventional liquid chemotherapy.
Benefits of PIPAC
- Effectiveness: Studies show that patients receiving PIPAC have improved overall survival rates and better tumor response.
- Safety: PIPAC is generally safe, with fewer severe side effects compared to traditional chemotherapy.
- Feasibility: Most patients can undergo multiple PIPAC treatments, leading to shorter hospital stays and enhanced quality of life.
Conclusion
PIPAC offers a promising alternative for patients with gastric cancer and peritoneal metastasis. It enhances the effectiveness of chemotherapy, reduces hospital stays, and improves survival rates. For more detailed information, please refer to the original study here.
Leave a Reply